Skip to main content

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

OTLK holding history

Outlook Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q2 2021
Holdings of OTLK by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−1,302−100.0%Sold outConverted for a 1-for-20 splitHolders
Q4 202326,030$10.3K<0.1%+5,880+29.2%AddedHolders
Q3 202320,150$4.45K<0.1%−24−0.1%ReducedHolders
Q2 202320,174$35.1K<0.1%+1,972+10.8%AddedHolders
Q1 202318,202$19.8K<0.1%+2,960+19.4%AddedHolders
Q4 202215,242$16.5K<0.1%+2,185+16.7%AddedHolders
Q3 202213,057$16.0K<0.1%−250−1.9%ReducedHolders
Q2 202213,307$13.0K<0.1%−8,049−37.7%ReducedHolders
Q1 202221,356$38.0K<0.1%+1,895+9.7%AddedHolders
Q4 202119,461$26.0K<0.1%+8,050+70.5%AddedHolders
Q3 202111,411$25.0K<0.1%−11,308−49.8%ReducedHolders
Q2 202122,719$57.0K<0.1%+22,719NewHolders